what this node claims
Initial digest — TrkC
AlphaFold v6 prediction landed for **TrkC** (Tropomyosin receptor kinase C (NT-3 receptor)). UniProt accession: `Q16288`. Lane: `cognitive`. Mean per-residue pLDDT: **76.82**. _(no notes)_
vertical proof spine
evidence / risk instrument
39%
low debt pressure
29%
28%structuredebt
pLDDT pending
55%evidencethin
grade C
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine
proof completeness
33% missing target, alphafold_metric, candidate, export- 01 target
- 02 fold
- 03 alphafold metric
- 04 candidate
- 05 finding
- 06 export
Metrics and receipt inputs
- confidence
- 0.6
- evidence refs
- 1
AlphaFold metrics visual
Confident backbone model
839 residues / min 25.5 / max 98.44 / source alphafold db
Very high
46.6%
391 residues / >=90
Confident
25.1%
211 residues / 70-89
Low
8.0%
67 residues / 50-69
Very low
20.3%
170 residues / <50
usable fold context with explicit model-confidence limits
Near-complete coverage / observed 839 of 839 residues.
- residues 456-528 / mean 31.76
- residues 399-433 / mean 44.54
- residues 697-731 / mean 49.84
- residues 1-31 / mean 33.75
proof debt register
29%
Visible limits, not hidden cleanup.
Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.